These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3987718)

  • 41. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
    Herrera C; Holberton J; Davis P
    Cochrane Database Syst Rev; 2004; (1):CD003480. PubMed ID: 14974018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Symptomatic patent ductus arteriosus in premature infants.
    Hwang B; Hsieh KS; Tsuei DH; Chen SJ; Meng CC
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Mar; 41(3):201-6. PubMed ID: 3263176
    [No Abstract]   [Full Text] [Related]  

  • 43. Indomethacin therapy in premature infants with patent ductus arteriosus.
    Rasidi C; Madiyono B; Usman IN
    Paediatr Indones; 1982; 22(3-4):70-6. PubMed ID: 7122105
    [No Abstract]   [Full Text] [Related]  

  • 44. [Drug therapy of patent ductus arteriosus in premature and newborn infants].
    Bartel J
    Kinderarztl Prax; 1978 Dec; 46(12):644-8. PubMed ID: 366238
    [No Abstract]   [Full Text] [Related]  

  • 45. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.
    Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE
    Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Closure of the ductus arteriosus by medication in low birth weight infants].
    Polgár M; Kemény J; Szirmai Z
    Orv Hetil; 1979 Oct; 120(43):2613-4. PubMed ID: 545236
    [No Abstract]   [Full Text] [Related]  

  • 47. Intravenous indomethacin therapy in premature infants with patent ductus arteriosus. Causes of death and one-year follow-up.
    Yeh TF; Goldbarg HR; Henek T; Thalji A; Pildes RS
    Am J Dis Child; 1982 Sep; 136(9):803-7. PubMed ID: 7114004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Asymptomatic reopening of ductus arteriosus after successful closure by indomethacin in premature infants.
    Yen SL; Teng RJ; Ho MM
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1993; 34(5):379-84. PubMed ID: 8237357
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Indomethacin treatment in small versus large premature infants with ductus arteriosus. Comparison of plasma indomethacin concentration and clinical response.
    Yeh TF; Luken J; Raval D; Thalji A; Carr I; Pildes RS
    Br Heart J; 1983 Jul; 50(1):27-30. PubMed ID: 6860508
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous indomethacin therapy.
    Crawshaw A
    J Paediatr Child Health; 1992 Apr; 28(2):198. PubMed ID: 1562379
    [No Abstract]   [Full Text] [Related]  

  • 51. Late closure of the ductus arteriosus using indomethacin in the preterm infant.
    Kresch MJ; Moya FR; Ascuitto RJ; Ross-Ascuitto NT; Heusser F
    Clin Pediatr (Phila); 1988 Mar; 27(3):140-3. PubMed ID: 3342597
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of patent ductus arteriosus in preterm infants].
    Jaso E; Tejedor JC; Quero J; Pérez Rodríguez J; Agustí B; Castro J; García Frías E
    An Esp Pediatr; 1982 Jun; 16(6):449-58. PubMed ID: 7125398
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Indomethacin treatment of persistent ductus arteriosus in premature infants].
    Petersen S; Christensen NC; Lauridsen P; Pedersen SA; Ryssing E
    Ugeskr Laeger; 1983 Nov; 145(46):3564-7. PubMed ID: 6649140
    [No Abstract]   [Full Text] [Related]  

  • 54. Indomethacin prophylaxis for patent ductus arteriosus (PDA) in infants with a birth weight of less than 1250 grams.
    Supapannachart S; Khowsathit P; Patchakapati B
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S87-92. PubMed ID: 10730525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants.
    ElHassan NO; Bird TM; King AJ; Ambadwar PB; Jaquiss RD; Kaiser JR; Robbins JM
    J Neonatal Perinatal Med; 2014 Jan; 7(3):229-35. PubMed ID: 25322995
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Ibuprofen--a new application for pharmacological closure of patent ductus arteriosus in preterm infants. Preliminary report].
    Adamska E
    Med Wieku Rozwoj; 2000; 4(2 Suppl 3):65-71. PubMed ID: 11328971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy.
    Quinn D; Cooper B; Clyman RI
    Pediatrics; 2002 Jul; 110(1 Pt 1):e10. PubMed ID: 12093991
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Indomethacin for preterm infants with intracranial hemorrhage.
    Chiba H; Masutani S; Toyoshima K; Mori R
    Pediatr Int; 2013 Feb; 55(1):124-6. PubMed ID: 23409994
    [No Abstract]   [Full Text] [Related]  

  • 59. Persistent Doppler flow predicts lack of response to multiple courses of indomethacin in premature infants with recurrent patent ductus arteriosus.
    Keller RL; Clyman RI
    Pediatrics; 2003 Sep; 112(3 Pt 1):583-7. PubMed ID: 12949288
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.